CHEEVER CHARLIE E III purchased $54K of CVSI

CHEEVER CHARLIE E III purchased 5,440,926 shares of CV Sciences, Inc. (CVSI) at $0.01 across 5 trades over 2026-11-04 to 2026-11-11.

Original reporting
SEC EDGAR · CHEEVER CHARLIE E III
Published Nov 16, 2026, 9:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CVSI
Neutral
medium confidence
Mentioned
$CVSI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVSINeutralLow
01

Why it matters

Insider buying can modestly influence sentiment, but without accompanying company-specific catalysts (earnings, guidance, deals, regulatory actions), the trading signal is likely weak.

02

Market read

Traders may note the insider buy as a sentiment datapoint, but the disclosed dollar amount is small and unlikely to reset valuation expectations.

03

What to watch

The trades occurred over multiple days (11/04 to 11/11) and the filing states no 10b5-1 plan, but the article provides no context on prior buying/selling patterns or valuation changes.

Relevance 4/10Novelty 6/10Timing: filed after-hours on 2026-11-16; reflects trades from 2026-11-04 to 2026-11-11

Background

The article is an SEC Form 4 insider transaction for CV Sciences, Inc., reported by a 10% owner.

Company-level read

Ticker impact

$CVSINeutralMedium confidence
Context

CV Sciences disclosed an insider open-market purchase by 10% owner Cheever totaling $54.4K across five trades at $0.0100/share (Form 4).

Expected impact

Likely limited near-term impact, with any reaction more sentiment-driven than fundamentals-driven.

Evidence & confidence

This is a primary SEC Form 4 disclosure, but the transaction value ($54.4K) is modest and does not include guidance, contracts, or regulatory/earnings developments.

Market effects

No clear sector read-through from a single small insider purchase.

None.

None.

Counterpoint

Insider purchases can be routine liquidity management or driven by pre-existing plans and do not necessarily indicate improved fundamentals, especially at microcap scale.

Key entities

  • CV Sciences, Inc.

    Subject of the Form 4 insider purchase disclosure.

  • CHEEVER CHARLIE E III

    10% owner who purchased shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CVSIMed

CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results San Diego, CA - November 12, 2026 (ACCESS Newswire) - CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp ex

$CVSIMed

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results San Diego, CA - August 13, 2026 (ACCESS Newswire) - CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp ext